Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,398 | 4,966 | 5,004 | 6,048 | 7,150 |
| Receivables | 410 | 33 | 27 | 77 | 25 |
| TOTAL | $4,819 | $5,022 | $5,052 | $6,230 | $7,307 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 22 | 36 | 49 | 63 | 76 |
| TOTAL | $22 | $36 | $49 | $63 | $76 |
| Total Assets | $4,842 | $5,058 | $5,101 | $6,293 | $7,382 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 601 | 587 | 154 | 479 | 689 |
| TOTAL | $627 | $627 | $208 | $536 | $744 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $10 | $26 |
| Total Liabilities | $627 | $627 | $208 | $547 | $769 |
| Shareholders' Equity | |||||
| Common Shares | 25,980 | 25,738 | 25,148 | 25,226 | 25,070 |
| Retained earnings | -25,060 | -24,405 | -23,392 | -22,328 | -21,112 |
| Other shareholders' equity | 3,294 | 3,097 | 3,137 | 2,849 | 2,656 |
| TOTAL | $4,215 | $4,431 | $4,893 | $5,746 | $6,613 |
| Total Liabilities And Equity | $4,842 | $5,058 | $5,101 | $6,293 | $7,382 |